
About Lantech Pharmaceuticals
Lantech Pharmaceuticals is an Industrial Goods & Manufacturing company based in Hyderabad (India). API manufacturing, intermediates production, and contract services in the pharmaceutical sector. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. Its Indian entity Aparna Organics Limited reported revenue of βΉ50.16 Cr. Lantech Pharmaceuticals offers products and services including Active Pharmaceutical Ingredients and Intermediates. Its focus areas include Manufacturing, Contract Services, Custom Manufacturing and Pharmaceuticals.
Company details
Aparna Pharmaceuticals is known for its involvement in the production of Active Pharmaceutical Ingredients and intermediates, with contract manufacturing services provided to global clients. Quality is maintained through dedicated facilities and regulatory compliance, while sustainability is addressed by adhering to environmental and social responsibilities. Operations are based in Hyderabad, India, where high-scale reactors support custom manufacturing needs for industry leaders. Ethical resource management is emphasized to meet statutory standards.
- Headquarters Hyderabad, India
- SectorsIndustrial Goods & ManufacturingHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Social LinkedIn
- Legal Name Aparna Organics Limited
- Date of Incorporation 21 Apr, 2008
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹50.16 Cr
FY 2023 · -57% YoY
- Net Loss-₹42.33 Cr
FY 2023 · -84% margin
- EBITDA-₹44.71 Cr
FY 2023 · -89% margin
Associated legal entities of Lantech Pharmaceuticals
Lantech Pharmaceuticals operates through Aparna Organics Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aparna Organics Limited CIN U24232TG2008PLC058745 | Amalgamated | 21 Apr 2008 | Hyderabad, Telangana | ₹50.2 Cr | 328 | 6 | View details |
Products & Services of Lantech Pharmaceuticals
Lantech Pharmaceuticals offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Intermediates.
Active Pharmaceutical Ingredients are produced using dedicated facilities and robust R&D processes to maintain consistency and quality for global markets.
Intermediates are manufactured with high volume efficiency and a range of reactors to supply high-quality products for emerging and regulated markets.
Board of directors of Aparna Organics Limited (Lantech Pharmaceuticals)
Aparna Organics Limited is the primary company behind Lantech Pharmaceuticals. The board of Aparna Organics Limited currently have 5 directors; the longest-serving is Pochana Aswin Reddy, appointed in 2021. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pochana Aswin Reddy DIN 01839213 | Director | 20 Mar 2021 | 5 yrs 7 mo | Aparna Organics Limited |
| Rakesh Reddy Chennuru DIN 00021490 | Managing Director | 20 Mar 2021 | 5 yrs 7 mo | Aparna Organics Limited |
| Venu Gopal Reddy Bommireddy DIN 01251924 | Director | 15 Feb 2022 | 4 yrs 8 mo | Aparna Organics Limited |
| Jeedigunta Venkata Sai Anil Kumar DIN 02107425 | Director | 15 Feb 2022 | 4 yrs 8 mo | Aparna Organics Limited |
| Kanumuri Sri Lakshmi Soma Satya Sita Rama Raju DIN 01790581 | Director | 18 Feb 2022 | 4 yrs 8 mo | Aparna Organics Limited |
Financials of Lantech Pharmaceuticals
Figures of Aparna Organics Limited, the primary company behind Lantech Pharmaceuticals, for FY 2023. Revenue was ₹50.16 Cr (-57% year on year). Net loss was -₹42.33 Cr (-84% margin). EBITDA was -₹44.71 Cr (-89% margin). Revenue has grown at a compounded annual rate of -31% over three years and -7% over five years.
- ₹50.16 CrRevenue · FY 2023 · -57% YoY
- -₹42.33 CrNet loss · -84% margin
- -₹44.71 CrEBITDA · -89% margin
- ₹16.85 CrPaid-up capital
- 328Employees (provident fund records)
- -31%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aparna Organics Limited are on its company page.
Detailed financial statements for Lantech Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Contract & Outsourced Manufacturing
3 companies that operate in the same segment as Lantech Pharmaceuticals (Contract & Outsourced Manufacturing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Industrial components, mould bases, and storage solutions are manufactured globally. | 1986 | Coimbatore, Tamil Nadu, India | USD 28 M | USD 853.09 M | 3,060 | |
Single- and three-phase transformers are manufactured in Mumbai. | 1993 | Mumbai, Maharashtra, India | USD 114.37 M | 618 | ||
Apparel and clothing are manufactured and exported on contract. | 1979 | Bengaluru, Karnataka, India | USD 400 M | 40,280 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lantech Pharmaceuticals
Lantech Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Lantech Pharmaceuticals, Aparna Organics Limited, reported revenue of βΉ50.16 Cr for FY 2023, down 57% year on year.
Aparna Pharmaceuticals is known for its involvement in the production of Active Pharmaceutical Ingredients and intermediates, with contract manufacturing services provided to global clients. Quality is maintained through dedicated facilities and regulatory compliance, while sustainability is addressed by adhering to environmental and social responsibilities. Operations are based in Hyderabad, India, where high-scale reactors support custom manufacturing needs for industry leaders. Ethical resource management is emphasized to meet statutory standards.
Lantech Pharmaceuticals offers Active Pharmaceutical Ingredients and Intermediates.
Lantech Pharmaceuticals operates through Aparna Organics Limited.
The legal entities of Lantech Pharmaceuticals currently have 6 directors, including Deepak Sunil Makhija, Pochana Aswin Reddy, Venu Gopal Reddy Bommireddy and others.